455 related articles for article (PubMed ID: 35351411)
21. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
[TBL] [Abstract][Full Text] [Related]
22. Circulating angiogenic proteins in trisomy 13.
Bdolah Y; Palomaki GE; Yaron Y; Bdolah-Abram T; Goldman M; Levine RJ; Sachs BP; Haddow JE; Karumanchi SA
Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
[TBL] [Abstract][Full Text] [Related]
23. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood.
Chaiworapongsa T; Romero R; Gotsch F; Suksai M; Gallo DM; Jung E; Krieger A; Chaemsaithong P; Erez O; Tarca AL
Am J Obstet Gynecol; 2023 May; 228(5):569.e1-569.e24. PubMed ID: 36336082
[TBL] [Abstract][Full Text] [Related]
24. Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.
Whitney JE; Zhang B; Koterba N; Chen F; Bush J; Graham K; Lacey SF; Melenhorst JJ; Teachey DT; Mensinger JL; Yehya N; Weiss SL
Crit Care Med; 2020 Mar; 48(3):344-352. PubMed ID: 32058372
[TBL] [Abstract][Full Text] [Related]
25. Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors.
Chaiworapongsa T; Romero R; Gomez-Lopez N; Suksai M; Gallo DM; Jung E; Berry SM; Awonuga A; Tarca AL; Bryant DR
Am J Obstet Gynecol; 2024 Apr; 230(4):450.e1-450.e18. PubMed ID: 37806612
[TBL] [Abstract][Full Text] [Related]
26. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia.
Krauss T; Kuhn W; Lakoma C; Augustin HG
Am J Obstet Gynecol; 1997 Aug; 177(2):443-9. PubMed ID: 9290466
[TBL] [Abstract][Full Text] [Related]
27. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
Woodham PC; Brittain JE; Baker AM; Long DL; Haeri S; Camargo CA; Boggess KA; Stuebe AM
Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
[TBL] [Abstract][Full Text] [Related]
28. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
29. First trimester angiogenic and inflammatory factors in women with chronic hypertension and impact of blood pressure control: a case-control study.
Nzelu D; Nicolaides KH; Kametas NA
BJOG; 2021 Dec; 128(13):2171-2179. PubMed ID: 34245653
[TBL] [Abstract][Full Text] [Related]
30. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
31. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
32. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.
Anto EO; Coall DA; Asiamah EA; Afriyie OO; Addai-Mensah O; Wiafe YA; Owiredu W; Obirikorang C; Annani-Akollor ME; Titiloye NA; Adua E; Acheampong E; Adu EA; Opoku S; Anto AO; Tawiah A; Wang Y; Wang W
PLoS One; 2022; 17(3):e0265717. PubMed ID: 35312727
[TBL] [Abstract][Full Text] [Related]
33. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.
Tuzcu ZB; Asicioglu E; Sunbul M; Ozben B; Arikan H; Koc M
Am J Obstet Gynecol; 2015 Oct; 213(4):533.e1-7. PubMed ID: 26116870
[TBL] [Abstract][Full Text] [Related]
34. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
35. Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
Arenas GA; Tang NY; Mueller A; Lopes Perdigao J; Kaur H; Abramowicz JS; Mussatt K; Yeo KJ; Rana S
Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100394. PubMed ID: 33991706
[TBL] [Abstract][Full Text] [Related]
36. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
Crispi F; Domínguez C; Llurba E; Martín-Gallán P; Cabero L; Gratacós E
Am J Obstet Gynecol; 2006 Jul; 195(1):201-7. PubMed ID: 16545329
[TBL] [Abstract][Full Text] [Related]
37. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.
Szarka A; Rigó J; Lázár L; Beko G; Molvarec A
BMC Immunol; 2010 Dec; 11():59. PubMed ID: 21126355
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
[TBL] [Abstract][Full Text] [Related]
39. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
Liu L; Wang R; Xu R; Chu Y; Gu W
Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
[TBL] [Abstract][Full Text] [Related]
40. Expert review: preeclampsia Type I and Type II.
Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
